Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 T cells take aim at cancer.

Literature DB >> 12461164

T cells take aim at cancer.

Drew Pardoll¹.

Abstract

Entities: Disease

Mesh：

Substances：
Interleukin-2

Year: 2002 PMID： 12461164 PMCID： PMC138522 DOI： 10.1073/pnas.262669499

Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN： 0027-8424 Impact factor: 11.205

× No keyword cloud information.

18 in total

1. IL-7 is critical for homeostatic proliferation and survival of naive T cells.

Authors: J T Tan; E Dudl; E LeRoy; R Murray; J Sprent; K I Weinberg; C D Surh
Journal: Proc Natl Acad Sci U S A Date: 2001-07-10 Impact factor: 11.205

Review 2. Spinning molecular immunology into successful immunotherapy.

Authors: Drew M Pardoll
Journal: Nat Rev Immunol Date: 2002-04 Impact factor: 53.106

3. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.

Authors: C Yee; J A Thompson; D Byrd; S R Riddell; P Roche; E Celis; P D Greenberg
Journal: Proc Natl Acad Sci U S A Date: 2002-11-11 Impact factor: 11.205

4. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response.

Authors: Y Sykulev; M Joo; I Vturina; T J Tsomides; H N Eisen
Journal: Immunity Date: 1996-06 Impact factor: 31.745

Review 5. Augmentation of host immune responses to cancer: overcoming the barrier of tumor antigen-specific T-cell tolerance.

Authors: H I Levitsky
Journal: Cancer J Date: 2000-05 Impact factor: 3.360

6. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes.

Authors: Mark E Dudley; John R Wunderlich; Paul F Robbins; James C Yang; Patrick Hwu; Douglas J Schwartzentruber; Suzanne L Topalian; Richard Sherry; Nicholas P Restifo; Amy M Hubicki; Michael R Robinson; Mark Raffeld; Paul Duray; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White; Steven A Rosenberg
Journal: Science Date: 2002-09-19 Impact factor: 47.728

Review 7. Principles for adoptive T cell therapy of human viral diseases.

Authors: S R Riddell; P D Greenberg
Journal: Annu Rev Immunol Date: 1995 Impact factor: 28.527

8. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.

Authors: S R Riddell; K S Watanabe; J M Goodrich; C R Li; M E Agha; P D Greenberg
Journal: Science Date: 1992-07-10 Impact factor: 47.728

Review 9. Tumor antigens recognized by T lymphocytes.

Authors: T Boon; J C Cerottini; B Van den Eynde; P van der Bruggen; A Van Pel
Journal: Annu Rev Immunol Date: 1994 Impact factor: 28.527

10. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells.

Authors: Joyce T Tan; Bettina Ernst; William C Kieper; Eric LeRoy; Jonathan Sprent; Charles D Surh
Journal: J Exp Med Date: 2002-06-17 Impact factor: 14.307

12 in total

1. Impact of comorbid anxiety and depression on quality of life and cellular immunity changes in patients with digestive tract cancers.

Authors: Fu-Ling Zhou; Wang-Gang Zhang; Yong-Chang Wei; Kang-Ling Xu; Ling-Yun Hui; Xu-Sheng Wang; Ming-Zhong Li
Journal: World J Gastroenterol Date: 2005-04-21 Impact factor: 5.742

2. A2A adenosine receptor protects tumors from antitumor T cells.

Authors: Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal: Proc Natl Acad Sci U S A Date: 2006-08-17 Impact factor: 11.205

Review 3. Impact of the immune system and immunotherapy in colorectal cancer.

Authors: Janet L Markman; Stephen L Shiao
Journal: J Gastrointest Oncol Date: 2015-04

4. Anticancer and immunostimulatory activity by conjugate of paclitaxel and non-toxic derivative of LPS for combined chemo-immunotherapy.

Authors: Aniruddha Roy; Sourav Chandra; Swapna Mamilapally; Pramod Upadhyay; Sangeeta Bhaskar
Journal: Pharm Res Date: 2012-05-01 Impact factor: 4.200